Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-19 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
M | Common Stock | A | 30554 | $6.00 - $6.00 | $183,324 |
2024-11-13 | Longboard Pharmaceuticals, Inc. | Lind Kevin Robert
(CEO) |
M | Common Stock | A | 12808 | $3.12 - $3.12 | $40,001 |
2024-11-13 | Longboard Pharmaceuticals, Inc. | Lind Kevin Robert
(CEO) |
G | Common Stock | D | 80000 | $0.00 - $0.00 | $0 |
2024-10-15 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
S | Common Stock | D | 16667 | $59.03 - $59.03 | $983,936 |
2024-10-15 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
M | Common Stock | A | 16667 | $4.35 - $4.35 | $72,501 |
2024-09-16 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
S | Common Stock | D | 16666 | $30.89 - $34.04 | $527,317 |
2024-09-16 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
M | Common Stock | A | 16666 | $4.35 - $4.35 | $72,497 |
2024-08-12 | Longboard Pharmaceuticals, Inc. | Lind Kevin Robert
(CEO) |
M | Common Stock | A | 82482 | $3.12 - $4.20 | $259,994 |
2024-06-25 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
S | Common Stock | D | 16767 | $20.87 - $35.03 | $580,890 |
2024-01-23 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
P | Common Stock | A | 100 | $24.82 - $24.82 | $2,482 |
2024-08-12 | Longboard Pharmaceuticals, Inc. | Kaye Randall
(CMO) |
M | Common Stock | A | 16667 | $4.35 - $4.35 | $72,501 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |